(Health-NewsWire.Net, August 09, 2016 ) About Chronic Obstructive Pulmonary Disease (COPD)
COPD is a chronic disease condition with a combination of symptoms of both chronic bronchitis and emphysema. Chronic bronchitis results in inflammation in the bronchioles, which results in increased mucus production. The condition is usually associated with a long-term cough with mucus. Emphysema results in the destruction of the walls of the alveoli, resulting in difficulty in breathing.
Technavios analysts forecast the global chronic obstructive pulmonary disease (COPD) drugs market to grow at a CAGR of 4.85% during the period 2016-2020.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=768106
Covered in this report The report covers the present scenario and the growth prospects of the global chronic obstructive pulmonary disease (COPD) drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat COPD.
The market is divided into the following segments based on geography: Americas APAC EMEA
Technavio's report, Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Content
PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights Breakthrough in COPD research COPD: An overview PART 05: Pipeline analysis PART 06: Market landscape Market overview Market size and forecast Five forces analysis PART 07: Key buying criteria for COPD drugs PART 08: Market segmentation by drug class Combination therapies Bronchodilators Steroids Leukotriene antagonists PDE-4 inhibitors Other medications
Contact Us:
Mr. Nachiket Albany NY - 12207 United States Tel: +1-518-621-2074 Tel: 866-997-4948 (Us-Canada Toll Free) Email: sales@researchmoz.us Follow us on LinkedIn at: http://bit.ly/1TBmnVG
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|